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Age-Associated Increase in Skin Fibroblast–Derived
Prostaglandin E2 Contributes to Reduced Collagen
Levels in Elderly Human Skin
Yong Li1, Dan Lei1, William R. Swindell1, Wei Xia1, Shinuo Weng2, Jianping Fu2, Christal A. Worthen1,
Toru Okubo1, Andrew Johnston1, Johann E. Gudjonsson1, John J. Voorhees1 and Gary J. Fisher1
Production of type I collagen declines during aging, leading to skin thinning and impaired function.
Prostaglandin E2 (PGE2) is a pleiotropic lipid mediator that is synthesized from arachidonic acid by the sequential
actions of cyclooxygenases (COX) and PGE synthases (PTGES). PGE2 inhibits collagen production by ﬁbroblasts
in vitro. We report that PTGES1 and COX2 progressively increase with aging in sun-protected human skin.
PTGES1 and COX2 mRNA were increased 3.4-fold and 2.7-fold, respectively, in the dermis of elderly (480 years)
versus young (21–30 years) individuals. Fibroblasts were the major cell source of both enzymes. PGE2 levels were
increased 70% in elderly skin. Fibroblasts in aged skin display reduced spreading due to collagen ﬁbril
fragmentation. To investigate the relationship between spreading and PGE2 synthesis, ﬁbroblasts were cultured
on micropost arrays or hydrogels of varying mechanical compliance. Reduced spreading/mechanical force
resulted in increased expression of both PTGES1 and COX2 and elevated levels of PGE2. Inhibition of PGE2
synthesis by diclofenac enhanced collagen production in skin organ cultures. These data suggest that reduced
spreading/mechanical force of ﬁbroblasts in aged skin elevates PGE2 production, contributing to reduced
collagen production. Inhibition of PGE2 production may be therapeutically beneﬁcial for combating age-
associated collagen deﬁcit in human skin.
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INTRODUCTION
Elderly skin is typically thin and fragile, with increased
susceptibility to bruising and impaired wound healing (Fisher
et al., 2008). These alterations largely reﬂect fragmentation
and reduction in type I collagen ﬁbrils, which comprise the
bulk of the dermal extracellular matrix (ECM) (Varani et al.,
2006). Dermal ﬁbroblasts secrete type I procollagen, which is
converted into collagen via proteolytic modiﬁcations. Mature
collagen self-assembles into collagen ﬁbrils, which are
stabilized by inter- and intra-ﬁbrillar cross-linking (Canty
and Kadler, 2005). Although mature cross-linked collagen
ﬁbrils are very stable, with a half-life of approximately 15
years (Verzijl et al., 2000), gradual cleavage, mediated by
matrix metalloproteases, occurs during aging (Fisher et al.,
2009). This cleavage results in the accumulation of cross-
linked fragments, owing to resistance of cross-links to
proteolysis. Thus, during aging, the dermal ECM becomes
progressively degraded and disorganized, which deleteriously
alters the function of resident ﬁbroblasts (Fisher et al.,
2008).
Fibroblasts attach to surrounding collagen ﬁbrils to form
adhesion complexes, which act through the cytoskeleton to
exert contractile forces. Resistance to this contraction
generates mechanical forces within ﬁbroblasts, which largely
determine morphology, cytoskeletal organization, signal
transduction, and gene expression (Tarutani et al., 2003;
Hegedus et al., 2008; Mammoto et al., 2013). Collagen
fragmentation causes loss of attachment sites, resulting in
reduced ﬁbroblast spreading, which is observed in aged
human skin. This contracted state, with concomitant reduced
mechanical force, is associated with downregulation of
collagen ﬁbril production in human skin (Varani et al.,
2006; Fisher et al., 2008; Xia et al., 2013).
PGE2 is a pleiotropic lipid signaling molecule produced
by multiple cell types (Humphrey et al., 2014). PGE2 is
synthesized from arachidonic acid by the sequential actions
of cyclooxygenases (COX1 and COX2) and prostaglandin E
synthases (PTGES1, 2, and 3) (Liu et al., 1995; Iskratsch et al.,
2014). Elevated COX2 often coincides with PTGES1 induction
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in a wide variety of tumor lesions and in response to
inﬂammatory stimuli (Verrecchia et al., 2001; Pickup et al.,
2013; Quan and Fisher, 2015). COX1, PTGES2, and PTGES3
are not typically inducible or involved in excess PGE2
production seen in abnormal conditions. PGE2 is a major
prostaglandin in human skin and is normally synthesized at
low levels but is markedly increased in skin squamous cell
carcinoma and inﬂammatory conditions, such as sunburn
(Muller-Decker, 2011). Non-steroidal anti-inﬂammatory drugs
are a class of commonly used drugs including aspirin,
ibuprofen, indomethacin, and diclofenac, which inhibit the
activities of both COX1 and COX2, thereby inhibiting PGE2
production (Qin et al., 2014). COX2 and PTGES1 induction in
response to acute inﬂammatory stimuli has been extensively
investigated (Verrecchia et al., 2001; Samuelsson et al., 2007;
Pickup et al., 2013; Quan and Fisher, 2015); however, the
potential effects of cellular mechanical forces on COX2 or
PTGES1 expression are unknown.
In cell cultures, PGE2 inhibits ﬁbroblast collagen produc-
tion, in part through impeding actions of transforming growth
factor-β (Sandulache et al., 2007). The inhibitory effect of
PGE2 on collagen synthesis has been shown to have a
protective role against lung ﬁbrosis, where impaired PGE2
production and action are implicated in excessive ﬁbroblast
collagen deposition (Huang et al., 2007).
This study reports that PTGES1 mRNA expression progres-
sively increases during aging and investigates the role of PGE2
in the age-related decline of type I collagen production in
human skin. Taken together, the data support the concept that
the dermal microenvironment raises PTGES1 and PGE2 levels,
which contributes to reduced collagen in aged skin. Given
that PGE2 synthesis can be effectively inhibited by a wide
range of agents (Qin et al., 2014), targeting PGE2 is an appealing
strategy to combat age-associated skin collagen deﬁciency.
RESULTS
PTGES1 mRNA expression progressively increases during aging
in human skin in vivo
In order to investigate age-related alterations in gene
expression, total RNA was extracted from full-thickness skin
samples obtained from sun-protected buttock skin of persons
between the ages of 18 and 75 (n= 62) (Swindell et al., 2012).
Global gene expression analysis was conducted using an
in situ oligonucleotide array platform (Affymetrix Human
Genome U133 Plus 2.0 array). Out of 19,851 human genes,
268 exhibited statistically signiﬁcant age-associated changes
in expression levels (false discovery rate o0.10). PTGES1
expression positively correlated with age, and this correlation
was the most statistically signiﬁcant. PTGES1 expression
was assessed by two probes targeting two different regions of
the PTGES1 transcript and yielded similar correlation
coefﬁcients and yearly rates of increase, as calculated by
linear regression. The results obtained from one probe,
210367_s_at, are shown in Figure 1a. The linear correlation
between increased PTGES1 expression and increased age
was highly statistically signiﬁcant (P= 2.6× 10− 7, n= 62),
and the degree of linearity, expressed as Pearson’s correlation
coefﬁcient, was r= 0.6 (r can vary from 0 to 1, with 0
representing no correlation and 1 representing perfect linear
correlation). When compared with young skin (18 years of
age), elderly skin (75 years of age) had a 1.6-fold overall
increase in PTGES1 expression.
In order to substantiate the age-associated increase in
PTGES1, we acquired buttock skin samples from an additional
40 subjects aged 21–94. Consistent with our microarray data,
PTGES1 expression progressively increased with age as
determined by quantitative PCR (qPCR) and increased 2.92-
fold overall in 94-year- versus 21-year-old skin (n= 40,
P= 1.38×10−7, r= 0.73) (Figure 1b). Taken together, these
data demonstrate an intriguing correlation between aging and
skin PTGES1 gene expression.
Dermal ﬁbroblasts are the primary source of increased
expression for both PTGES1 and COX2 mRNA in aged human
skin
Elevation of COX2 expression often occurs concomitantly
with PTGES1 induction. However, COX2 mRNA levels in
whole skin preparations did not signiﬁcantly differ between
young and aged individuals (data not shown). We hypothe-
sized that dermal expression of PTGES1 and COX2 mRNA
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Figure 1. PTGES1 mRNA expression progressively increases in human skin
during chronological aging. (a) Relative PTGES1 mRNA expression in human
buttock skin was determined by cDNA microarray analysis. Results show
positive correlation of the PTGES1 mRNA level and age of donors (n=62,
P= 2.6× 10−7, r=0.60). (b) PTGES1 mRNA expression in buttock skin was
determined by qPCR. (n=40, P= 1.38 10−7, r=0.73). The subjects used in
microarray analysis were different from the subjects used in qPCR analysis.
cDNA, complementary DNA.
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may account for age-dependent differences. In order to
determine dermal and epidermal PTGES1 and COX2 expres-
sion, we used laser capture microdissection of skin sections,
followed by qPCR. Consistent with our hypothesis, dermal,
but not epidermal, PTGES1 and COX2 gene expression were
signiﬁcantly different in young versus aged individuals.
PTGES1 and COX2 levels were signiﬁcantly increased 3.4-
fold (Po0.05) and 2.7-fold, respectively (Po0.05), in aged
dermis (Figure 2a and b). This ﬁnding suggests that aging
dermal, but not epidermal, cells express more PTGES1 and
COX2.
In order to determine whether ﬁbroblasts are responsible for
elevated dermal PTGES1 gene expression, we separated
ﬁbroblasts from other dermal cells in skin samples using
anti-ﬁbroblast antibody-coated magnetic microbeads. Fibro-
blast enrichment was validated by mRNA quantiﬁcation of
several cell markers (Supplementary Table S1 online). Isolated
cells were directly analyzed without culturing. PTGES1
mRNA levels were approximately 10-fold (Po0.05) higher
in ﬁbroblast-enriched cells than in ﬁbroblast-depleted dermal
cells (Figure 2c). These data indicate that dermal ﬁbroblasts
are responsible for the majority of dermal PTGES1 expression.
In order to determine whether dermal ﬁbroblasts are
responsible for the changes to PTGES1 expression in aging,
we isolated ﬁbroblasts from young (21–30 years) and aged
(480 years) skin. Consistent with our data, PTGES1 mRNA
expression was 2.2-fold higher in ﬁbroblasts from aged skin
(Po0.05) (Figure 2d). We also quantiﬁed COX2 mRNA
expression in isolated ﬁbroblasts; however, COX2 mRNA
levels in freshly isolated ﬁbroblasts were markedly elevated
by the isolation process. Taken together, the data suggest that
dermal ﬁbroblasts are the primary cell source of elevated
PTGES1 and COX2 mRNA expression in aged skin.
PTGES1 protein expression is elevated in skin ﬁbroblasts of
elderly (480 years) versus young (21–30 years) individuals
In order to determine whether PTGES1 protein levels were
increased in aged dermal ﬁbroblasts, we performed immuno-
histochemistry on both young and aged skin samples. Positive
staining that overlapped with or was immediately adjacent to
the nuclei was most prominently seen in dermal stromal cells
in both young and aged skin. In addition, PTGES1-positive
dermal cells displayed morphology characteristic of ﬁbro-
blasts, including being embedded in collagenous ECM
without direct contact with other cells or structures, elongated
cell bodies, and oval shaped nuclei (Figure 3). Statistical
analysis showed that the percentage of positively stained
dermal stromal cells was increased 2.1-fold (75 vs. 35%,
Po0.01) in aged skin. These data suggest that PTGES1 protein
is preferentially expressed by ﬁbroblasts, and ﬁbroblast-
derived PTGES1 protein expression is increased in the aged
dermis, consistent with increased PTGES1 mRNA expression
(Figure 2).
COX2 protein expression was also examined by immuno-
histochemistry but did not yield speciﬁc staining, consistent
with previous studies showing that COX2 protein expression
in normal human skin is below the limit of immunohisto-
chemistry detection (Hoot et al., 2010).
PGE2 levels are higher in elderly versus young skin
Age-associated increases in COX2 and PTGES1 likely result in
enhanced PGE2 production. To examine this possibility, we
incubated fresh samples of buttock skin from young (21–30
years) and aged (480 years) persons in culture medium for
5 minutes and quantiﬁed PGE2 levels in the conditioned
media. PGE2 levels were 1.7-fold higher (Po0.05) in skin
specimens from elderly individuals (Figure 4). Taken together,
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Figure 2. Dermal ﬁbroblasts are a major cell source for increased expression of PTGES1 and COX2 in aged (480 years) versus young (21–30 years) skin. The
dermis and the epidermis of frozen skin sections were separated and collected using laser capture microscopy. Relative (a) PTGES1 and (b) COX2 mRNA levels in
the epidermis and dermis of young and aged individuals were determined by qPCR normalized to 36B4 mRNA. n=6, *Po0.05. (c and d) Cells were released
from fresh sun-protected skin samples by collagenase digestion. Released cells were fractionated by immuno-afﬁnity magnetic beads to separate ﬁbroblasts for
other cell types. Total RNA was extracted from isolated cells. (c) PTGES1mRNA levels were determined in ﬁbroblast-enriched and ﬁbroblast-depleted cells (n=4,
*Po0.05). (d) PTGES1 mRNA levels were determined in ﬁbroblast-enriched cells isolated from skin samples from young and aged individuals. (n=5–7,
*Po0.05).
Y Li et al.
PGE2 Mediates Collagen Loss in Elderly Skin
www.jidonline.org 2183
these data indicate that increased COX2 and PTGES1
expression in aged dermal ﬁbroblasts is associated with
increased PGE2 production in human skin in vivo.
Enhanced ECM compliance elevates COX2 and PTGES1
expression and PGE2 synthesis in primary adult human dermal
ﬁbroblasts
Reduced ﬁbroblast spreading/mechanical force is considered
a driving force of ﬁbroblast dysfunction in elderly skin (Fisher
et al., 2008). We therefore examined whether PTGES1 and
COX2 expression were regulated by changes to ECM
compliance. For these studies, we utilized micropost arrays
and hydrogel assays. Fibroblasts were cultured on a micropost
array with two different compliances––low compliance
(15.3 kPa) and high compliance (1.3 kPa).
Electron micrographs (Figure 5a) of ﬁbroblasts adhered to
type I collagen-coated micropost arrays revealed bending of the
microposts through cytoskeleton contractile forces. More
compliant microposts (1.3 kPa) were more deformed, resulting
in reduced ﬁbroblast spreading, resembling ﬁbroblasts seen in
fragmented collagenous ECM of aged dermis in vivo (Fisher
et al., 2008). Less compliant microposts (15.3 kPa) resisted
deformation and ﬁbroblasts had a spread morphology,
resembling the stretched ﬁbroblasts seen in the intact
collagenous ECM of young dermis in vivo (Figure 5a). On
average, ﬁbroblasts cultured on 1.3 kPa microposts displayed a
7.9-fold lower traction force compared with those cultured on
15.3-kPa microposts (Figure 5b), as measured by calculating the
number of posts deformed by a cell, as well as the degree of
deformation. These data conﬁrm that ﬁbroblasts grown on a less
compliant ECM experience more mechanical force.
To determine the effect of mechanical force on PGE2
production, PTGES1 and COX2 mRNA expression were
measured in ﬁbroblasts cultured on 15.3 kPa and 1.3 kPa
microposts. PTGES1 and COX2 expression increased by 1.7-fold
and 3.0-fold, respectively, when cultured on more compliant
(1.3 kPa) compared with less compliant (15.3 kPa) microposts
(Figure 5c). In addition, PGE2 levels in the conditioned media
increased by 1.9-fold (Figure 5d), indicating that increased ECM
compliance results in increased PGE2 production.
To further conﬁrm the stimulatory effects of high ECM
compliance on PGE2 synthesis, we analyzed ﬁbroblasts
cultured on type I collagen-coated polyacrylamide hydrogels.
Fibroblasts cultured on a more compliant hydrogel (7 kPa)
exhibited increased PTGES1 (2.0-fold) and COX-2 (3.8-fold)
mRNA expression and enhanced PGE2 levels (4.5-fold)
compared with ﬁbroblasts cultured on a less compliant
30 kPa hydrogel (Figure 5e and f). In concert with changes
of PGE2, but in an opposite direction, procollagen mRNA
and protein expression were increased by 2.2- and 2.8-fold,
respectively, in 30 kPa hydrogels compared with 7 kPa
hydrogels (Supplementary Figure S1 online). Taken together,
these data indicate that increased ECM compliance results in
reduced ﬁbroblast spreading/mechanical force, which leads
to enhanced PGE2 production and reduction in procollagen
expression.
PGE2 inhibits procollagen production in human dermal
ﬁbroblasts
We next assessed the effects of PGE2 on collagen production
of ﬁbroblasts from young (21–30 years) skin. Fibroblasts were
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cultured in serum-free medium in the presence of PGE2 or
vehicle (DMSO) for 24 hours. Type I procollagen protein was
examined by western blot. PGE2 treatment reduced procolla-
gen protein levels by approximately 66% (Po0.05)
(Figure 6a).
In order to determine whether inhibition of PGE2 produc-
tion can enhance collagen production, we examined the
effect of the general COX inhibitor, diclofenac, and the
COX2-speciﬁc inhibitor, celecoxib, in organ culture of skin
samples obtained from buttock skin. Fresh skin biopsies were
cultured in the presence of inhibitor or vehicle (DMSO) for
16 hours. Type I procollagen protein in conditioned medium
was quantiﬁed by enzyme immunoassay (EIA). Biopsies also
underwent RNA extraction for quantiﬁcation of type I
procollagen expression. Diclofenac signiﬁcantly reduced
PGE2 levels by 92± 7% (n=3, Po0.05, data not shown)
and enhanced procollagen mRNA and protein expression by
2.3-fold and 1.9-fold, respectively (Po0.05) (Figure 6b).
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Figure 5. Reduced spreading/mechanical force elevates COX2 and PTGES1 expression and prostaglandin E2 (PGE2) levels in human skin ﬁbroblasts.
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are representative of three experiments examining 460 ﬁbroblasts. (b) Quantiﬁcation of traction force (nanonewton, nN) for 10 ﬁbroblasts/condition (n=3,
*Po0.001). (c) COX2 and PTGES1 mRNA levels were determined by qPCR (n=3, *Po0.05). (d) PGE2 levels in conditioned medium were quantiﬁed by EIA and
normalized to cell number (n=3, *Po0.05). (e and f) Fibroblasts cultured from young skin were seeded on type I collagen-coated hydrogels with low or high
compliance. (e) PTGES1 and COX2 mRNA levels were quantiﬁed by qPCR. (n=3, *Po0.05). (f) PGE2 levels in conditioned media quantiﬁed by EIA. (n=3,
*Po0.05). EIA, enzyme immunoassay.
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Celecoxib reduced PGE2 levels by approximately 80%, and
enhanced procollagen mRNA expression by 1.9-fold
(Supplementary Figure S2 online), suggesting that PGE2
derived from COX2 is largely responsible for inhibition of
procollagen expression in human skin organ cultures. The
results are consistent with the notion that increased COX-2
expression in aged dermis can lead to increased PGE2
production and consequently reduced collagen expression.
DISCUSSION
Chronological aging is a progressive process driven by the
accumulation and synergy of subtle alterations, resulting in
declining organ structure and function. Because of its
accessibility, the skin is an ideal organ for investigating the
cumulative nature of aging and its underlying causalities in
humans (Fisher et al., 2008). Age-related increase in PTGES1
mRNA and protein expression was consistently revealed by
examining whole skin, isolated dermis, and freshly isolated
ﬁbroblasts, using different methods and different groups of
donors. Fibroblasts in aged human skin displayed comparable
increases in mRNA (2.2-fold) and protein (2.1-fold) levels,
although direct quantitative comparisons between results
obtained from two different techniques should be interpreted
with caution.
Although we found that epidermal COX2 and PTGES1
mRNA expression do not differ between young and aged, the
results do not exclude the possibility that aged epidermal cells
may also contribute to enhanced PGE2 levels observed in
aged skin. The relative contribution of dermal and epidermal
cells to enhanced PGE2 levels observed in whole skin
specimens remains to be determined by future investigations.
We have proposed that age-associated molecular and
cellular alterations in the dermis create a self-perpetuating
cycle that drives the progression of ECM degeneration (Fisher
et al., 2014). Age-associated fragmentation of collagen ﬁbrils
impairs interactions of ﬁbroblasts with the collagenous ECM,
leading to suppression of collagen production and enhanced
production of matrix metalloproteases, which collectively
cause further deterioration of the ECM. Impaired ECM causes
further ﬁbroblast dysfunction in a self-sustaining loop (Varani
et al., 2006; Fisher et al., 2008; Xia et al., 2013). This study
implicates PGE2 in this self-perpetuating cycle. Impaired ECM
causes reduced mechanical force within ﬁbroblasts, which in
turn elevates COX2 and PTGES1 gene expression, likely
through activations of transcription factors such as NF-kB,
which are known to regulate expression of these two genes
(Bage et al., 2010).
Several age-associated alterations found in skin ﬁbroblasts
in vivo may conspire to cause reduced collagen production in
the context of collagen ﬁbril fragmentation. In addition to
PGE2, previous studies have found reduced expression of
connective tissue growth factor/CCN2 and enhanced expres-
sion of CCN1 (cysteine-rich protein 61) in aged human skin
ﬁbroblasts. These alterations inhibit collagen production, at
least in part, through blockade of transforming growth factor-β
signaling (Quan et al., 2006; Quan et al., 2010; He et al.,
2014). Therapeutics targeting these pathways may retard or
reverse the decline of skin collagen production during aging,
thereby improving skin health. Elevated PGE2 is an appealing
target for intervention, as PGE2 production in human skin can
be effectively reduced by topical non-steroidal anti-inﬂam-
matory drugs (Qin et al., 2014). This study provides rationale
for investigation into the potential beneﬁcial effects of non-
steroidal anti-inﬂammatory drugs for collagen deﬁciency in
elderly skin. Mice models that display elevated skin PGE2
levels and resultant collagen reduction would provide
opportunity for both further mechanistic studies and evalua-
tion of agents that could retard age-related collagen deﬁ-
ciency via the inhibition of PGE2 synthesis and actions.
In addition to a possible contribution to collagen deﬁ-
ciency, ﬁbroblast-derived PGE2 may be a risk factor for other
prevalent age-associated skin disorders. PGE2 may impair
functions of adjacent immune cells and epidermal keratino-
cytes via a paracrine mechanism. Given the critical role of
PGE2 in promoting cutaneous squamous cell carcinoma and
inhibiting functions of antigen-presenting cells required for
allergenic contact dermatitis, elevated ﬁbroblast-derived
PGE2 may contribute to the observed increase in skin cancer
and reduced skin immunity in the elderly (Muller-Decker,
2011; Scott et al., 2014). In addition to local effects, skin-
derived PGE2 has been demonstrated to have a systemic
impact. This effect is mediated by transit of PGE2 and PGE2-
induced cytokines into the circulation (Soontrapa et al., 2011;
Ullrich and Byrne, 2012; Scott et al., 2014). Whether
constitutively elevated PGE2 in chronologically aged, sun-
protected, skin impacts other organ systems is an intriguing
question for future investigations.
MATERIALS AND METHODS
Human tissue procurement
Full-thickness skin biopsies (2, 4, and 6mm in diameter) were taken
from buttocks of healthy human subjects as previously described
(Li et al., 2013). All procedures involving human subjects were
approved by the University of Michigan Institutional Review Board.
Informed written consent was obtained from all human subjects.
Complementary DNA microarray analysis
Affymetrix Human Genome U133 Plus 2.0 arrays (54,675 probe-sets
of 19,851 genes) were used for expression proﬁling (Santa Clara, CA).
Normalized expression values were calculated using the robust
multichip average algorithm (Irizarry et al., 2003). One probe-set was
analyzed for each gene. The representative probe-set was chosen by
the highest average robust mulitichip average expression intensity
among all 62 samples. Raw robust mulitichip average intensities
were adjusted to remove gender and batch variation. Simple linear
regression was then used to identify genes signiﬁcantly changed with
age. Raw P-values were adjusted using the Benjamini-Hochberg
method (Benjamini and Hochberg, 1995). False discovery rate
-adjusted P-value threshold of 0.10 was used.
Laser-capture microdissection
Laser capture microdissection was performed as previously described
(Li et al., 2013). Brieﬂy, 30 tissue sections were prepared from
each skin biopsy embedded in optimal cutting temperature.
Appendage-free dermis and interfollicular-epidermis were separately
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collected using laser capture microdissection (Leica ASLMD System;
Leica Microsystems, Wetzlar, Germany).
Fibroblast isolation
Skin biopsies were digested with collagenase (5 mgml− 1 in DMEM)
for 16 hours at 37 °C as described previously (Li et al., 2013).
Fibroblasts that were released from the dermis were separated from
other cell types using anti-ﬁbroblast Microbeads (Miltenyi Biotec,
San Diego, CA) according to the manufacturer’s instruction.
Cell culture
Fibroblasts were cultured from punch biopsies (6 mm) from buttock
skin (aged 21–30 years) and maintained as previously described
(Fisher et al., 2009). Fibroblasts between passages 3 and 8 were used
in this study.
RNA extraction and qPCR
RNA was extracted using an RNA extraction kit (Qiagen, Chatsworth,
CA). qPCR reagents were from Applied Biosystems (Foster City, CA).
Ribosomal protein 36B4 was used to normalize gene expression (Li
et al., 2013).
Micropost arrays and hydrogels
Polydimethylsiloxane micropost arrays were fabricated, analyzed by
scanning electron microscopy, and used for ﬁbroblast traction force
measurements, as previously described (Fu et al., 2010; Bonnans
et al., 2014). Hydrogels were fabricated on glass coverslips as
previously described (Caulin et al., 2007).
Protein extraction and western blot analysis
Protein extraction from primary ﬁbroblasts and western analysis were
performed as previously described (Li et al., 2013).
Immunohistochemistry
Immunohistochemistry was performed with anti-PTGES1 mouse
monoclonal antibody (Santa Cruz Biotech, Santa Cruz, CA) on
frozen skin sections as previously described (Rittie et al., 2009).
Fifteen microscopic ﬁelds of each section were used for quantitation
of cell staining.
PGE2 enzyme immunoassay (EIA)
After excision, skin buttock biopsies (2 mm) were immediately
incubated in 200 μl α-MEM medium for 5 minutes. PGE2 levels in
the conditioned media were quantiﬁed using the EIA assay (Cayman,
Ann Arbor, MI). DNA was extracted from skin biopsies using the
Micro-DNA Extraction Kit (Qiagen) and quantiﬁed by ultraviolet
spectrometry. PGE2 levels were normalized to DNA content in
corresponding biopsies. This method was validated by quantifying
increased PGE2 levels in skin biopsies from acute ultraviolet-
irradiated skin, compared with non-irradiated skin.
Type I procollagen EIA from organ cultures
Fresh skin biopsies were cultured in the presence of diclofenac or
vehicle (DMSO) for 16 hours. Type I procollagen in organ culture
conditioned medium was determined by an EIA kit (Takara Bio, Otsu
Shiga, Japan) and normalized to total protein based on the
manufacturer’s instruction.
Statistical analysis
The correlations between PTGES1 levels and age were analyzed
using linear regression. Differences between two groups of samples
were analyzed using the two-tailed t-test. Differences were con-
sidered signiﬁcant when Po0.05. Data are presented as mean±
standard error of mean. N numbers represent sample size of
each group.
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